We are live on
!
Find out more
SFM
Soros Fund Management Portfolio holdings
AUM
$9.12B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+30.69%
3 Year Est. Return
+70.05%
5 Year Est. Return
+69.93%
10 Year Est. Return
+534.14%
AUM
$6.02B
AUM Growth
-$1.63B
(-21%)
Cap. Flow
-$2.86B
Cap. Flow
% of AUM
-47.53%
Top 10 Holdings %
Top 10 Hldgs %
29.65%
Holding
274
New
78
Increased
32
Reduced
34
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$81.5M |
| 2 |
Aramark
ARMK
|
+$46.4M |
| 3 |
WRK
WestRock Company
WRK
|
+$39.3M |
| 4 |
Okta
OKTA
|
+$39.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$241M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$239M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$90.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$82.4M |
| 5 |
State Street SPDR EURO STOXX 50 ETF
FEZ
|
+$65.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Industrials | 7.12% |
| 3 | Financials | 5.45% |
| 4 | Communication Services | 5.11% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
MP Materials
MP
$8.45B
| $8.37M | 0.14% |
+585,209
| New | +$9.26M |
|
102
Sixth Street Specialty
TSLX
$1.78B
| $7.93M | 0.13% |
+370,000
| New | +$7.95M |
|
|
AAMI
103
Acadian Asset Management
AAMI
$3.26B
| $7.91M | 0.13% |
346,293
| – | – |
|
104
Edwards Lifesciences
EW
$51.5B
| $7.17M | 0.12% |
+75,000
| New | +$6.3M |
|
105
Kosmos Energy
KOS
$1.47B
| $7.15M | 0.12% |
+1,200,409
| New | +$7.22M |
|
106
DexCom
DXCM
$31.3B
| $6.93M | 0.12% |
50,000
-60,000
| -55% | -$7.54M |
|
107
JPMorgan Chase
JPM
$947B
| $6.91M | 0.11% |
+34,500
| New | +$6.23M |
|
108
Invesco QQQ Trust
QQQ
$479B
| $6.66M | 0.11% |
+15,000
| New | +$6.43M |
|
|
AY
109
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $6.47M | 0.11% |
350,000
| – | – |
|
110
Pacific Biosciences
PACB
$363M
| $6.12M | 0.1% |
+1,633,000
| New | +$9.56M |
|
111
Natera
NTRA
$38B
| $5.94M | 0.1% |
65,000
-85,000
| -57% | -$6.39M |
|
112
Qualcomm
QCOM
$168B
| $5.93M | 0.1% |
35,000
+5,000
| +17% | +$773K |
|
113
Hamilton Insurance Group
HG
$3.53B
| $5.69M | 0.09% |
408,634
-112,841
| -22% | -$1.64M |
|
114
DuPont de Nemours
DD
$19.5B
| $5.58M | 0.09% |
+58,001
| New | +$5.16M |
|
115
Corebridge Financial
CRBG
$15.2B
| $5.57M | 0.09% |
194,000
-35,000
| -15% | -$864K |
|
116
Enterprise Products Partners
EPD
$82.3B
| $5.54M | 0.09% |
190,000
| – | – |
|
117
First Citizens BancShares
FCNCA
$25.5B
| $5.45M | 0.09% |
3,333
| – | – |
|
118
CALL
Unity
U
$18B
| $5.34M | 0.09% |
200,000
-400,000
| -67% | -$12.6M |
|
119
3M
MMM
$93.2B
| $5.3M | 0.09% |
+59,800
| New | +$4.96M |
|
120
GE Aerospace
GE
$389B
| $5.27M | 0.09% |
+37,590
| New | +$4.43M |
|
|
SAGE
121
DELISTED
Sage Therapeutics
SAGE
| $5.15M | 0.09% |
+275,000
| New | +$6.34M |
|
|
BBOT
122
BridgeBio Oncology
BBOT
$703M
| $4.94M | 0.08% |
+475,000
| New | +$4.92M |
|
123
Carrier Global
CARR
$52.7B
| $4.92M | 0.08% |
+84,716
| New | +$4.76M |
|
124
TSMC
TSM
$2.17T
| $4.63M | 0.08% |
34,047
-45,953
| -57% | -$5.71M |
|
125
Privia Health
PRVA
$2.77B
| $4.41M | 0.07% |
225,000
+25,000
| +13% | +$528K |
|
Similar funds
RWP
LCAM
VAS
A
HKAM
SUT
AI
AI
Soros Fund Management's Q1 2024 Portfolio in Review
As of Q1 2024, Soros Fund Management held 274 positions worth $6.02B, down 21% from $7.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Soros Fund Management withdrew a net $2.86B in Q1 2024, closing 81 positions and reducing 34 holdings. Its most notable exit was Splunk Inc, an estimated $241M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5% a quarter earlier, followed by Industrials and Financials.
Against the trend, Soros Fund Management opened a new position in Cerevel Therapeutics Holdings, Inc. Common Stock worth $82M.
- Soros Fund Management's largest Q1 2024 buy was Cerevel Therapeutics Holdings, Inc. Common Stock: 1,940,201 shares worth $82M.
- Soros Fund Management added most to Aramark in Q1 2024, an estimated $46.4M increase.
- Soros Fund Management's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $90.1M.
- Soros Fund Management fully exited Splunk Inc in Q1 2024, selling an estimated $241M.
- Soros Fund Management's ten largest holdings make up 30% of its $6.02B portfolio in Q1 2024.
- Soros Fund Management opened 78 new positions and closed 81 in Q1 2024.
- Soros Fund Management's portfolio value fell 21% quarter-over-quarter to $6.02B.
Based on Soros Fund Management's 13F filing for Q1 2024, filed 15 May 2024.